Mounjaro Missed Dose Management: Skip and Resume at Same Dose
If you miss a Mounjaro dose by more than 4 days, you skip that missed dose entirely and administer your next scheduled dose at the SAME strength you were already taking—not escalating to the next higher dose. For example, if you were on 2.5 mg and missed by more than 4 days, your next injection remains 2.5 mg, not 5 mg 1.
The 4-Day Rule
The FDA-approved dosing instructions for Mounjaro establish a clear time-based algorithm 1:
- Within 4 days (96 hours) of missed dose: Administer the missed dose as soon as possible, then resume your regular weekly schedule
- More than 4 days past the missed dose: Skip that dose completely and give the next dose on your regularly scheduled day at your current maintenance dose
Why You Don't Advance to the Next Dose
The confusion often arises because patients conflate two separate concepts:
- Scheduled dose escalation (the planned 4-week titration from 2.5 mg → 5 mg → 7.5 mg, etc.)
- Missed dose management (what to do when you forget an injection)
These are independent processes. Missing a dose does not trigger automatic advancement through the titration schedule. The 2.5 mg starting dose exists specifically for treatment initiation and gastrointestinal tolerability—it's not intended for glycemic control 1. However, once you've completed your 4-week period on 2.5 mg and moved to 5 mg (or any maintenance dose), a missed injection simply means you skip that particular injection and continue at your established dose level.
Practical Example
Let's say you're on 2.5 mg weekly, scheduled for Mondays:
Scenario A: You forget Monday's dose but remember on Thursday (3 days late)
- Action: Inject 2.5 mg immediately on Thursday
- Next dose: Resume regular Monday schedule with 2.5 mg
Scenario B: You forget Monday's dose and don't remember until Saturday (5 days late)
- Action: Skip this dose entirely—do NOT inject
- Next dose: Wait until next Monday and inject 2.5 mg (your current maintenance dose)
- If you were already scheduled to escalate to 5 mg after completing 4 weeks on 2.5 mg, that escalation timing remains based on your original schedule, not the missed dose
The Rationale: Pharmacokinetics and Safety
Tirzepatide has a plasma elimination half-life of approximately 5 days 2. The 4-day window reflects a balance between maintaining therapeutic drug levels and avoiding excessive overlap that could increase gastrointestinal adverse events (nausea, vomiting, diarrhea affect 25-50% of patients) 3, 4.
Skipping after 4 days prevents:
- Overlapping doses that could cause severe GI symptoms
- Unpredictable drug accumulation
- Increased risk of dose-dependent adverse effects including acute gallbladder disease 1
Dose Escalation Remains Schedule-Based
Your progression through tirzepatide doses (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg for adults) should occur only after at least 4 weeks on each dose level and only if additional glycemic control is needed 1. This titration schedule is designed to minimize gastrointestinal adverse reactions, which are the primary reason for treatment discontinuation 4, 5.
Real-world data shows that 84.1% of patients initiate at ≤5 mg, and by the sixth prescription refill, 56.5% remain on doses <10 mg 6. The majority of patients (69.6%) experience at least one dose escalation during the first 6 months, with mean time to first escalation of 59 days 6. This underscores that dose advancement is a deliberate, clinically-driven decision—not an automatic consequence of missed doses.
Common Pitfall to Avoid
Do not attempt to "catch up" by doubling doses or advancing prematurely to the next strength. The evidence from similar once-weekly medications (insulin icodec, somapacitan) consistently shows that doses missed beyond 3-4 days should simply be skipped, with resumption at the regular maintenance dose 7, 2, 7. This "wait-and-see" strategy is appropriate given tirzepatide's relatively short half-life and the ceiling effect seen with supra-therapeutic doses of GLP-1/GIP agonists 8.
Changing Your Weekly Injection Day
If needed, you can change your weekly administration day as long as at least 3 days (72 hours) separate two doses 1. This flexibility allows schedule adjustments without compromising safety or efficacy.